IDEXX Laboratories, Inc. vs Southern Copper Corp — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Southern Copper Corp trades at $209.14 (market cap $167.74B). The key difference: Southern Copper Corp is far larger — about 4.1× IDEXX Laboratories, Inc.'s market cap, and Southern Copper Corp pays a 2.21% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Southern Copper Corp for 61 Days on average.
| IDXX | SCCO | |
|---|---|---|
Market Cap | $40.43B | $167.74B |
Volume | 692,164 | 853,110 |
Sector | Health | Basic Materials |
52-Week High | $766.68 | $219.70 |
52-Week Low | $504.70 | $120.02 |
Typical Hold Time | 46 Days | 61 Days |
Enterprise Value | $41.32B | $169.03B |
Dividend Yield | — | 2.21% |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Southern Copper (SCCO) trades at $209.21, up 4.31% with strong earnings momentum, beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 35.87% net margins and 50.07% ROE. Recent news highlights the company's $10.2B Mexican project pipeline as a long-term growth driver while current sentiment remains mixed amid copper price volatility.
SCCO presents a valuation premium with P/E of 29.81 and P/S of 10.72, trading above analyst consensus target of $167.67. While operational excellence and project pipeline support upside potential, elevated valuation and bearish technicals suggest near-term caution. The stock faces headwinds from copper market volatility and competitive pressures in the materials sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →